Biotech

All Articles

ReNeuron leaving behind intention substitution after missing out on fundraising objective

.ReNeuron has actually joined the lengthy listing of biotechs to leave behind London's goal stock ma...

MBX apply for IPO to take challenger to Ascendis into phase 3

.MBX Biosciences has contributed to the latest flurry of IPO filings. The biotech, which submitted i...

FDA extends probe right into Lykos' MDMA tests: WSJ

.For Lykos Rehabs and also the firm's would-be MDMA-assisted treatment for trauma (PTSD), the hits s...

Gene editor Volume giving up 131 laborers

.Only times after gene publisher Volume Biosciences introduced unrevealed working slices, a clearer ...

Repare gives up 25% of team as biotech halts preclinical R&ampD

.Repare Therapeutics is giving up an one-fourth of its own staff as the oncology biotech scales back...

J &amp J apply for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually taken another action toward realizing a yield on its $6.5 billion...

Gain's period 1 win paves method to show Parkinson's drug's worth

.Gain Rehabs has prepared its own sights on confirming the effectiveness of its Parkinson's illness ...

Actinogen reports brand-new phase 2 information to restore anxiety medication

.Actinogen Medical's hopes-- and sell price-- have rebounded somewhat from earlier this month, when ...

Pfizer and also Front runner incorporate Ratio to multibillion-dollar formula

.Main Pioneering and Pfizer have added Ratio right into their 10-program alliance, inking a package ...

Bayer markers $547M contract to push limits of noncoding RNA

.Bayer executives were eager to anxiety to Intense this summer season that the German pharma giant's...